myelopeptide 1 has been researched along with Agammaglobulinemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borisova, AM; Glazko, AV; Petrov, RV; Simonova, AV; Stepanenko, RN | 1 |
| Borisova, AM; Glazko, AV; Golenkov, AK | 1 |
| Apostoloff, E; Grunow, R; Hiepe, F; Jahn, S; Kiessig, ST; Volk, HD; Von Baehr, R | 1 |
3 other study(ies) available for myelopeptide 1 and Agammaglobulinemia
| Article | Year |
|---|---|
[Efficacy of myelopid in immunodeficiency states].
Topics: Activins; Adjuvants, Immunologic; Adolescent; Adult; Agammaglobulinemia; B-Lymphocytes; Bronchitis; Chronic Disease; Female; Humans; Immune Tolerance; Leukocyte Count; Middle Aged; Multiple Sclerosis; Oligopeptides; Peptides; Pneumonia; Remission Induction; T-Lymphocytes | 1990 |
[Effect of human regulatory myelopeptides on the elaboration of a factor inhibiting leukocyte migration].
Topics: Activins; Agammaglobulinemia; B-Lymphocytes; Bone Marrow; Humans; Leukocyte Migration-Inhibitory Factors; Lymphokines; Multiple Myeloma; Oligopeptides; Peptides | 1988 |
A myelopeptide from unstimulated bone marrow cells with immunomodulatory activity in lymphocyte cultures from healthy donors and patients with hypogammaglobulinemia and active lupus erythematosus.
Topics: Agammaglobulinemia; Bone Marrow; Cells, Cultured; Female; HLA-D Antigens; Humans; Immunoglobulin G; Immunoglobulin M; In Vitro Techniques; Lupus Erythematosus, Systemic; Lymphocytes; Male; Oligopeptides; Peptide Biosynthesis; Peptides | 1988 |